Delivering successful antibody leads for your development pipeline
On our mission to bridge the gap between research innovation and novel therapies, YUMAB has built an advanced discovery platform for next generation biotherapeutics. We provide access to challenging targets and new formats at high speed and success rate to lead drug developers worldwide through the discovery process as trusted, de-risking partner.
A powerful integraton of innovative technologies – rapid, robust, reliable
The YUMAB® platform provides all technologies for a fully integrated human antibody development in one company. We offer individually designed, work package-based contract research projects – from your target molecule to your engineered and optimized antibody lead candidate. Single technology modules or combinations thereof are also available as R&D service to assist your antibody program at every stage.
OUR DISCOVERY PROCESS
A 3-step fast track from target to lead